http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : 안세나(Sena An) (검색결과 1 건)
- 무료
- 기관 내 무료
- 유료
-
박혜영(Hae-Young Park),안세나(Sena An),전수민(Soo Min Jeon),권진원(Jin-Won Kwon) 대한약학회 2020 약학회지 Vol.64 No.5
Studies on the burden of disease for the patients with non-Hodgkin’s lymphoma (NHL) which accounts for about 90 percent of lymphoma are still insufficient. Thus, this study was conducted to assess mortality and economic burden of NHL overall and subtypes. This analysis based on a sample cohort database from the National Health Insurance Sharing Service. ICD-10 codes were used to select NHL patients (C82-86, C96) and to classify subtype of NHL. A retrospective cohort design was applied and patients and their matching controls were compared on survival and medical expenditure using Cox hazard proportion model and generalized linear regression. The 5-year survival rates were 66.2% in NHL total patients (n=521) and 61.7% in diffuse large B-cell lymphoma and male and aged ≥80 showed higher risk for survival. The 5-year cumulative medical expenditure after first diagnosis of NHL was 37.1 million won, and about 44% of the expenses were spent during the first year. The 5-year costs were 4.09 times higher than those of controls, and comorbidity index, older age, and death increased the medical expenditure. In conclusion, NHL caused lower survival and higher medical costs compared to the non-cancer controls, and this study confirmed that subtype of NHL, gender, age, comorbidity and death had a significant impact on the burden of the disease.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
